Aniz Girach

Company: Splice Bio

Job title: Ophthalmologist, Board Director, Chief Medical Officer, Head R&D

Seminars:

Optimizing Endpoint Selection in Ophthalmic Gene Therapy Trials 9:00 am

Choosing appropriate endpoints is pivotal for accurately evaluating the efficacy of ophthalmic gene therapy. This workshop provides a cohesive exploration of innovative strategies to enhance endpoint selection, ensuring validity, reliability, and patient-centricity in ocular gene therapy trials. Key Discussion Points: Advancing Visual Function Assessment: Exploring advancements in visual function assessment methodologies tailored for gene therapy…Read more

day: Pre-Conference Workshop Day Clinical Track AM